🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this prospective randomized multicenter intervention study i...
Status
Completed
Location
Deutsches Institut für Ernährungsforschung / Charité Berlin
Start Date
2012-03
Trial ID
NCT01947595
Treatments Being Tested
Hypertension and diabetes are major risk factors for cardiovascular disease...
Status
Completed
Location
CHCs and District Hospital of Solan District
Start Date
2012-12
Trial ID
NCT01794052
Treatments Being Tested
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
A parallel-group randomized controlled trial that will evaluate the efficac...
Status
Completed
Location
The Aga Khan University
Start Date
2020-01-13
Trial ID
NCT04216446
Treatments Being Tested
Adults and adolescents will be asked to participate in a 10-week interventi...
Status
Completed
Location
Texas A&M University
Start Date
2023-01-01
Trial ID
NCT05725408
The purpose of this study is to evaluate the sensitivity and specificity of...
Status
Completed
Location
Medical University of South Carolina
Start Date
2024-01-16
Trial ID
NCT06038175
Treatments Being Tested
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
In literature, it has been reported that exercise capacity decreases in sin...
Status
Completed
Location
Hacettepe University
Start Date
2021-09-20
Trial ID
NCT05063903
The purpose of this randomised (double-blind) controlled exercise intervent...
Status
Terminated
Location
Kaukaharjun Seniorikeskus
Start Date
2011-10
Trial ID
NCT01523600
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested